Lutathera (lutetium Lu 177 dotatate) - Novartis
Clinical Applications of Real-Time Patient Monitoring using Novel Ceiling Monitors in MRT facilities (EANM 2026) - Sep 29, 2026 - Abstract #EPS-169; Pres time: Oct 20, 2026; 08:00 AM - 09:30 AM; Location: Hall G2; "This study demonstrates that real-time monitoring using ceiling-mounted radiation detectors has significant benefits for patients treated with I-131. These include: early identification of delayed excretion, enabling clinical intervention to promote activity clearance; shortening of hospitalisation (reducing attendant risks) and more accurate prediction of patient-specific retained activity - the latter supporting personalised radiation restrictions. Potential future applications include other MRTs benefitting from more accurate dosimetry, such as paediatric treatments or those utilising Lu-177 DOTATATE/ PSMA." 
Clinical • Solid Tumor • Thyroid Gland Carcinoma
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
J. Mohammed-Gayle 1; E. Crick 1; H. Buschhold 1, 2; R. Fernandez 1
 
Sep 29, 2026
 
Prev Next